Michael Panzara
2021
In 2021, Michael Panzara earned a total compensation of $1.5M as Chief Medical Officer, Head of Therapeutics Discovery and Development at Wave Life Sciences Ltd., a 86% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $212,000 |
|---|---|
| Option Awards | $331,500 |
| Salary | $471,000 |
| Stock Awards | $524,000 |
| Other | $9,942 |
| Total | $1,548,442 |
Panzara received $524K in stock awards, accounting for 34% of the total pay in 2021.
Panzara also received $212K in non-equity incentive plan, $331.5K in option awards, $471K in salary and $9.9K in other compensation.
Rankings
In 2021, Michael Panzara's compensation ranked 7,122nd out of 12,397 executives tracked by ExecPay. In other words, Panzara earned more than 42.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,122 out of 12,397 | 43rd |
Division Manufacturing | 3,110 out of 5,492 | 43rd |
Major group Chemicals And Allied Products | 1,372 out of 2,367 | 42nd |
Industry group Drugs | 1,222 out of 2,090 | 42nd |
Industry Pharmaceutical Preparations | 892 out of 1,537 | 42nd |
Source: SEC filing on June 29, 2022.
Panzara's colleagues
We found two more compensation records of executives who worked with Michael Panzara at Wave Life Sciences Ltd. in 2021.